487
Participants
Start Date
September 18, 2016
Primary Completion Date
January 25, 2020
Study Completion Date
January 25, 2020
Oxytocin nasal spray
Intranasal administration of 24 International Units, Oxytocin will be given 30 minutes before the fear extinction task (Study 1) or fMRI measurement (Study 2).
Placebo nasal spray
The placebo spray contains the identical ingredients, except for the peptide itself. It will be given 30 minutes before the fear extinction task (Study 1) or fMRI measurement (Study 2).
Estrogen Gel
Participants received a single dose of estradiol gel (Estramon 2 mg estradiol, Hexal AG, Holzkirchen, Germany), applied to their shoulder, 3 hours prior to the fear extinction task (Study 1) or fMRI measurement (Study 2).
Placebo Gel
Participants received a single dose of the placebo gel (ultrasonic gel, 2 mg), applied to their shoulder, 3 hours prior to the fear extinction task (Study 1) or fMRI measurement (Study 2).
Deparment of Psychiatry and Medical Psychology, Bonn
University Hospital, Bonn
OTHER